Funding for this research was provided by:
National Health and Medical Research Council (1026864)
Text and Data Mining valid from 2018-07-03
Received: 15 January 2018
Accepted: 14 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: The Ethical Review Committee (ERC) of the icddr,b, and the Human Research Ethics Committee (HREC) of University of Sydney have granted ethics approval for this study. Any amendment to the protocol will be communicated to both the ERC. We obtained written informed consent, from pregnant women during enrolment into the study, which provided full disclosure regarding the study. We will strictly maintain the privacy, anonymity and confidentiality of the information provided by respondents during all phases of the trial. All information will be stored in an encrypted database with participant’s study ID instead of personal identifiers, and none but the associated investigators and data management team will have access to collected data.
: Not applicable.
: The authors declare that they do not have any competing interest. Eskayef, the manufacturer of iron-folic acid supplements used in the study, has no involvement in the study conception, design, implementation, collection and interpretation of data.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.